AR and prostate cancer: Subsequently, DHT and T bind to and initiate androgen receptor (AR) nuclear translocation, which results in AR target gene transcription that modulates cell cycle, apoptosis, cell differentiation, and other processes necessary for the development and progression of prostate cancer [3,4,5].